Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Series Seed Convertible Preferred Stock [Member]	Series A Convertible Preferred Stock [Member]	Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Balance at Dec. 31, 2021	$ (64,203)				$ 1	$ 1,185	$ (65,389)
Balance (in Shares) at Dec. 31, 2021		5,000,000	41,666,666	37,499,999
Balance at Dec. 31, 2021		$ 2,350	$ 49,762	$ 89,744
Balance (in Shares) at Dec. 31, 2021					909,418
Issuance of common stock upon exercise of stock options	55					55
Issuance of common stock upon exercise of stock options (in Shares)					31,725
Vesting of restricted common stock (in Shares)					2,285
Stock-based compensation expense	332					332
Net loss	(9,853)						(9,853)
Balance at Mar. 31, 2022	(73,669)				$ 1	1,572	(75,242)
Balance (in Shares) at Mar. 31, 2022		5,000,000	41,666,666	37,499,999
Balance at Mar. 31, 2022		$ 2,350	$ 49,762	$ 89,744
Balance (in Shares) at Mar. 31, 2022					943,428
Balance at Dec. 31, 2021	(64,203)				$ 1	1,185	(65,389)
Balance (in Shares) at Dec. 31, 2021		5,000,000	41,666,666	37,499,999
Balance at Dec. 31, 2021		$ 2,350	$ 49,762	$ 89,744
Balance (in Shares) at Dec. 31, 2021					909,418
Net loss	(35,583)
Balance at Sep. 30, 2022	(98,527)				$ 1	2,444	(100,972)
Balance (in Shares) at Sep. 30, 2022		5,000,000	41,666,666	37,499,999
Balance at Sep. 30, 2022		$ 2,350	$ 49,762	$ 89,744
Balance (in Shares) at Sep. 30, 2022					965,034
Balance at Mar. 31, 2022	(73,669)				$ 1	1,572	(75,242)
Balance (in Shares) at Mar. 31, 2022		5,000,000	41,666,666	37,499,999
Balance at Mar. 31, 2022		$ 2,350	$ 49,762	$ 89,744
Balance (in Shares) at Mar. 31, 2022					943,428
Issuance of common stock upon exercise of stock options	86					86
Issuance of common stock upon exercise of stock options (in Shares)					8,768
Vesting of restricted common stock (in Shares)					2,285
Stock-based compensation expense	382					382
Net loss	(9,580)						(9,580)
Balance at Jun. 30, 2022	(82,781)				$ 1	2,040	(84,822)
Balance (in Shares) at Jun. 30, 2022		5,000,000	41,666,666	37,499,999
Balance at Jun. 30, 2022		$ 2,350	$ 49,762	$ 89,744
Balance (in Shares) at Jun. 30, 2022					954,481
Issuance of common stock upon exercise of stock options	22					22
Issuance of common stock upon exercise of stock options (in Shares)					8,269
Vesting of restricted common stock (in Shares)					2,284
Stock-based compensation expense	382					382
Net loss	(16,150)						(16,150)
Balance at Sep. 30, 2022	(98,527)				$ 1	2,444	(100,972)
Balance (in Shares) at Sep. 30, 2022		5,000,000	41,666,666	37,499,999
Balance at Sep. 30, 2022		$ 2,350	$ 49,762	$ 89,744
Balance (in Shares) at Sep. 30, 2022					965,034
Balance at Dec. 31, 2022	176,600				$ 2	288,814	(112,216)
Balance (in Shares) at Dec. 31, 2022					17,403,315
Issuance of common stock upon exercise of stock options	1,067					1,067
Issuance of common stock upon exercise of stock options (in Shares)					74,753
Vesting of restricted common stock (in Shares)					958
Stock-based compensation expense	1,024					1,024
Sale of common stock in registered direct offering	34,148					34,148
Sale of common stock in registered direct offering, Shares					1,488,166
Sale of pre-funded warrants in registered direct offering	28,206					28,206
Sale of common stock in at-the-market offerings	14,591					14,591
Sale of common stock in at-the-market offerings, Shares					608,050
Net loss	(22,781)						(22,781)
Balance at Mar. 31, 2023	232,855				$ 2	367,850	(134,997)
Balance (in Shares) at Mar. 31, 2023					19,575,242
Balance at Dec. 31, 2022	$ 176,600				$ 2	288,814	(112,216)
Balance (in Shares) at Dec. 31, 2022					17,403,315
Issuance of common stock upon exercise of stock options (in Shares)	175,191
Issuance of common stock upon exercise of warrants (in Shares)	1,229,221
Net loss	$ (52,850)
Balance at Sep. 30, 2023	358,974				$ 2	524,038	(165,066)
Balance (in Shares) at Sep. 30, 2023					24,139,078
Balance at Mar. 31, 2023	232,855				$ 2	367,850	(134,997)
Balance (in Shares) at Mar. 31, 2023					19,575,242
Issuance of common stock upon exercise of stock options	242					242
Issuance of common stock upon exercise of stock options (in Shares)					41,475
Vesting of restricted common stock (in Shares)					958
Stock-based compensation expense	1,309					1,309
Sale of common stock in follow on public offering, Shares					3,015,919
Sale of common stock in In follow on public offering	138,508					138,508
Sale of pre-funded warrants in follow-on public offering	9,373					9,373
Sale of common stock in at-the-market offerings	4,879					4,879
Sale of common stock in at-the-market offerings, Shares					217,300
Net loss	(15,947)						(15,947)
Balance at Jun. 30, 2023	371,219				$ 2	522,161	(150,944)
Balance (in Shares) at Jun. 30, 2023					22,850,894
Issuance of common stock upon exercise of stock options	607					607
Issuance of common stock upon exercise of stock options (in Shares)					58,963
Stock-based compensation expense	1,270					1,270
Issuance of common stock upon exercise of warrants (in Shares)					1,229,221
Net loss	(14,122)						(14,122)
Balance at Sep. 30, 2023	$ 358,974				$ 2	$ 524,038	$ (165,066)
Balance (in Shares) at Sep. 30, 2023					24,139,078